Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

FDA approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma

FDA approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial...

$FDA grants accelerated approval to zanubrutinib for relapsed or refractory follicular lymphoma$

FDA grants accelerated approval to zanubrutinib for relapsed or refractory follicular lymphoma

Rising alcohol-related liver cancer prompts new prediction tool

Rising alcohol-related liver cancer prompts new prediction tool

Pilot confirms feasibility, acceptability of bowel symptom intervention studies

Pilot confirms feasibility, acceptability of bowel symptom intervention studies

Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer

Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer

Discovered a RNA molecule that helps prevent DNA replication errors

Discovered a RNA molecule that helps prevent DNA replication errors

Deciphering the male breast cancer genome

Deciphering the male breast cancer genome

Newly discovered protein prevents DNA triplication

Newly discovered protein prevents DNA triplication

Cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

Cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

New microbiome insights could help boost immunotherapy for a range of rare cancers

New microbiome insights could help boost immunotherapy for a range of rare cancers

More from ecancer